eptinezumab
Wed, 11 May 2022 09:44:37 -0400
For the prevention of migraine in adults who have at least 4 migraine days per month.
Italiano
Wed, 11 May 2022 09:44:37 -0400
For the prevention of migraine in adults who have at least 4 migraine days per month.
Wed, 11 May 2022 09:23:17 -0400
Tue, 10 May 2022 13:12:26 -0400
For the treatment of patients with transfusional iron overload due to sickle cell disease (SCD) or other anemias.
Tue, 10 May 2022 13:01:45 -0400
For the treatment of adults and pediatric patients with atypical hemolytic uremic syndrome (aHUS) to inhibit complement-mediated thrombotic microangiopathy (TMA).
The FDA is warning people not to use the Skippack Medical Lab SARS-CoV-2 Antigen Rapid Tests. The test’s performance has not been adequately established.
SML Distribution Recalls Unauthorized COVID-19 Direct Antigen Rapid Tests because they are not authorized, cleared, or approved by the FDA.
Mon, 09 May 2022 13:54:44 -0400
For the treatment of adult patients with diabetic macular edema (DME) who are pseudophakic and have had an inadequate response to prior anti-vascular endothelial growth factors (VEGF) therapy.
Mon, 09 May 2022 13:42:30 -0400
Cablivi (caplacizumab) is indicated for the treatment of adults with acquired thrombotic thrombocytopenic purpura (aTTP) in combination with plasma exchange (PE) and immunosuppressive therapy.
Mon, 09 May 2022 10:34:59 -0400
Mesa BioTech’s Accula SARS-CoV-2 Tests are being recalled because facility contamination may cause them to give false positive results.
80.211.154.110